Skip to main content
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. — Investor Relations & Filings

Ticker · DARE ISIN · US23666P1012 US Manufacturing
Filings indexed 731 across all filing types
Latest filing 2026-06-01 Proxy Solicitation & In…
Country US United States of America
Listing US DARE

About Dare Bioscience, Inc.

https://www.darebioscience.com/

Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative products for women's health. The company conducts end-to-end clinical development of therapies designed to address unmet needs in areas such as contraception, sexual health, vaginal health, and menopause. Its pipeline includes candidates like Ovaprene®, a hormone-free monthly contraceptive, and a topical sildenafil cream for female sexual arousal disorder. Dare Bioscience emphasizes a rigorous, science-based approach to develop medically credible and evidence-based solutions, aiming to close critical gaps in female healthcare.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement
2026-06-01 English
DEFA14A
Proxy Solicitation & Information Statement
2026-06-01 English
8-K
Capital/Financing Update Classification · 92% confidence The document is a Form 8-K “Current Report” disclosing the closing of a Regulation A offering of equity securities (Series A Convertible Preferred Stock and warrants) and details of share issuance and fundraising. This is an update on a financing activity/ capital raise. Therefore, it should be classified under Capital/Financing Update (CAP).
2026-05-18 English
10-Q
Interim / Quarterly Report Q1 2026
2026-05-14 English
8-K
Regulatory Filings Classification · 93% confidence The document is a Form 8-K current report under the Securities Exchange Act, furnishing a press release on quarterly financial results via Exhibit 99.1. It does not contain the actual earnings data itself (the release is attached as an exhibit), nor is it the full interim report or a proxy or dividend notice. This is a compliance/regulatory filing announcing the release of results. Therefore it best fits the “Regulatory Filings” category (RNS).
2026-05-14 English
ARS - Dare Bioscience, Inc. (0001401914) (Filer)
Annual Report FY 2025
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.